- Home
- Companies
- Ecomed Solutions
- Products
- Ecomed HEMAsavR - Blood Management ...
Ecomed HEMAsavR - Blood Management Device
The HEMAsavR™ device provides a sterile, economical method for capturing and transferring blood during surgical procedures. Its integration into surgical settings enables efficient blood collection and salvage, thereby reducing the need for costly allogeneic blood transfusions. The device's closed, sterile system is compatible with surgical suction and autotransfusion systems, ensuring seamless incorporation into existing protocols and workflows. Utilizing HEMAsavR™ allows clinical teams to quickly respond to unexpected blood loss, improving patient outcomes by decreasing the risks associated with allogeneic transfusions, such as infections and multi-organ failures. The system features a patented sampling port for accurate blood loss quantification and allows the return of washed, autologous blood to the patient, enhancing recovery and reducing hospital and ICU stays. HEMAsavR™ supports a comprehensive blood management program, offering solutions to collect, process, and reinfuse blood efficiently and cost-effectively.
HEMAsavR™ will reduce allogeneic blood transfusions and improve patient care.
The HEMAsavR™ device is a sterile, economical blood capture and transfer device that supports efforts to collect and salvage blood in most surgical procedures—allowing clinicians to respond quickly to unanticipated blood loss. The HEMAsavR™ decreases the upfront cost of collecting shed blood and creates options to improve outcomes and avoid allogeneic transfusions.
Utilize HEMAsavR™ to respond quickly to unanticipated blood loss in surgical and post-surgical settings. Make HEMAsavR™ part of your blood management program today.
COLLECT MORE
- Shed blood is a significant source of RBCs
- Leverage existing protocols and workflow for blood salvage
- Closed, sterile system compatible with surgical suction & autotransfusion systems
SAVE MORE
- Designed to reduce allogeneic transfusions which are among the costliest contributors to healthcare expenditures
- Seamless integration. Collection does not require specialized resources
IMPROVED OUTCOMES
- By avoiding allogeneic tranfusion-related adverse events:
-
- Decrease patient mortality
- Lower incidence of nosocomial infections
- Reduce risk of multi-organ failures
- Decrease length of hospital and ICU stays